Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04957615 |
|---|---|
| Brief Title: | Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression |
| First Submitted : | July 1, 2021 |
| First Submitted that Met QC Criteria : | July 1, 2021 |
| First Posted : | July 12, 2021 |
| Last Update Submitted that Met QC Criteria : | May 9, 2023 |
| Last Update Posted : | May 11, 2023 |